|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
|
|---|---|---|---|---|---|
| Revenues from contracts with customers | |||||
| Initial recognition and changes in the fair value of biological assets at the point of harvest | |||||
| Total | |||||
| Cost of sales | |||||
| Changes in the net realizable value of agricultural products after harvest | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Share of profit or loss of joint ventures and associates | |||||
| Other income or expenses, net | |||||
| Operating (loss)/ profit | |||||
| Financial cost | |||||
| Other financial results | |||||
| (Loss)/ Profit before income tax | |||||
| Income tax | |||||
| (Loss)/ Profit for the year | |||||
| Other comprehensive (loss) | |||||
| Items that may be subsequently reclassified to (loss)/ profit | |||||
| Foreign exchange differences on translation of foreign operations from joint ventures | |||||
| Foreign exchange differences on translation of foreign operations | |||||
| Items that will not be subsequently reclassified to loss and profit | |||||
| Revaluation of property, plant and equipment, net of tax, of joint ventures and associates 1 | |||||
| Revaluation of property, plant and equipment, net of tax 2 | |||||
| Total comprehensive (loss)/ profit | |||||
| Total comprehensive (loss)/ profit attributable to: | |||||
| Equity holders of the parent | |||||
| Non-controlling interests | |||||
| (Loss)/Profit per share | |||||
| Basic loss attributable to ordinary equity holders of the parent | |||||
| Diluted loss attributable to ordinary equity holders of the parent | |||||
| Basic | |||||
| Diluted | |||||
| (Loss) / Profit for the year attributable to: | |||||
| Equity holders of the parent | |||||
| Non-controlling interests | |||||
Loading...
